Is VOQP or ORCC a better dividend investment in 2026?

VOQP currently yields 66666.67% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: VOQP offers higher current income.

What is the dividend yield difference between VOQP and ORCC?

VOQP has a forward dividend yield of 66666.67% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 66656.88 percentage points.

Home › Compare › VOQP vs ORCC

VOQP vs ORCC: Dividend Comparison 2026

VOQP yields 66666.67% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VOQP wins by $8.441837856534449e+24M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VOQP

● Live price

66666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.441837856534449e+24M

Annual income

$8,417,001,582,403,749,000,000,000,000,000.00

Full VOQP calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — VOQP vs ORCC

📍 VOQP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VOQP	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VOQP + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VOQP pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VOQP

Annual income on $10K today (after 15% tax)

$5,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$7,154,451,345,043,187,000,000,000,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, VOQP beats the other by $7,154,451,345,043,187,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VOQP + ORCC for your $10,000?

VOQP: 50%ORCC: 50%

100% ORCC50/50100% VOQP

Portfolio after 10yr

$4.2209189282672247e+24M

Annual income

$4,208,500,791,201,874,400,000,000,000,000.00/yr

Blended yield

99.71%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

VOQP

No analyst data

Altman Z

-74.1

Piotroski

1/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VOQP buys

ORCC buys

Politician	Chamber	Ticker	Type	Amount	Date
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-23
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$250,001 - $500,000	2022-06-16
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-14
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-13
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-10
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-09
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-08
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-03
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-05-24
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$100,001 - $250,000	2022-05-20

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVOQPORCC

Forward yield	66666.67% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$8.441837856534449e+24M	$21.4K ✓
Annual income after 10y	$8,417,001,582,403,749,000,000,000,000,000.00 ✓	$1.04
Total dividends collected	$8.44020886744369e+24M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: VOQP vs ORCC ($10,000, DRIP)

Year	VOQP Portfolio	VOQP Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$6,677,367	$6,666,666.67	$11,190	$489.61	+$6.67M → VOQP
2	$4,167,497,846	$4,160,353,063.34	$12,229	$256.01	+$4167.49M → VOQP
3	$2,431,161,901,635	$2,426,702,678,939.67	$13,216	$130.74	+$2431161.89M → VOQP
4	$1,325,636,209,022,888	$1,323,034,865,788,139.00	$14,207	$66.02	+$1325636209.01M → VOQP
5	$675,632,775,263,916,700	$674,214,344,520,262,300.00	$15,234	$33.17	+$675632775263.90M → VOQP
6	$321,867,481,182,444,260,000	$321,144,554,112,911,900,000.00	$16,317	$16.62	+$321867481182444.25M → VOQP
7	$143,326,993,661,751,470,000,000	$142,982,595,456,886,240,000,000.00	$17,468	$8.32	+$143326993661751472.00M → VOQP
8	$59,657,925,421,851,500,000,000,000	$59,504,565,538,633,426,000,000,000.00	$18,695	$4.16	+$59657925421851500544.00M → VOQP
9	$23,211,471,150,187,795,000,000,000,000	$23,147,637,169,986,416,000,000,000,000.00	$20,006	$2.08	+$2.3211471150187796e+22M → VOQP
10	$8,441,837,856,534,450,000,000,000,000,000	$8,417,001,582,403,749,000,000,000,000,000.00	$21,407	$1.04	+$8.441837856534449e+24M → VOQP

VOQP vs ORCC: Complete Analysis 2026

VOQP — Stock

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products' lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.

Full VOQP Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this VOQP vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VOQP vs SCHD VOQP vs JEPI VOQP vs O VOQP vs KO VOQP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.